The Latest

Zydus Pharmaceuticals Of India Continues Its Five Year Trend Of Failed FDA Inspections

The FDA continues to allow products from these labs to be sold in the U.S. because it is often more concerned with supply than safety.

FDA Issues Another Toothless Warning Letter To India Generic Drug Giant Aurobindo

Chinese and Indian manufacturers receive the most FDA warning letters for violations of good manufacturing practices.

7 views

Study Finds Over 90% of all Generic Drugs Dependent on Imports

Other countries have made investments in API facilities; the U.S. is falling further behind.

FDA’s Latest Eye Drop Recalls Are All Made Overseas

The FDA recalled 28 different eye drop products sold over-the-counter in retail pharmacies like CVS and Target.

Indian Generic Drug Exporters Have A Month Full Of Recalls

This summer ended with one recall after the next for Indian pharmaceutical companies that export generic drugs to the United States.

Glass in Vial Forces Indian Multinational Drug Company Aurobindo to Recall Products In U.S.

Aurobindo recalled 1,626 vials of Triamcinolone Acetonide Injectable Suspension, an important generic corticosteroid treatment.

FDA Says U.S. Approved India Psychotropic Drug Maker Has Dirty Lab

The FDA is returning to a normal overseas inspection workload. What they are finding is not pretty.

FDA Again Allows Unapproved Chinese Chemotherapy Drugs into the U.S.

The FDA approved Qilu Pharmaceuticals from Shandong, China, to sell the generic oncology drug cisplatin along with carboplatin.